House passes $901B military defense bill after Republican revolt collapses

The House approved the FY NDAA 312-112, authorizing roughly $901 billion for the Pentagon and sending a negotiated package to the Senate after a narrow, late procedural win; the bill includes $400 million a year in Ukraine aid for two years and provisions preventing the administration from cutting troop levels in Europe and South Korea or pausing weapons deliveries to Ukraine. Policy wins for conservatives include a 4% enlisted pay raise, elimination of DEI programs, $20 billion in cuts to “obsolete” Pentagon spending, and an FBI disclosure requirement for investigations of federal candidates, while the bill omits recent IVF coverage and AI-preemption language. Significant economic-security measures could affect markets and cross-border deals: an outbound-investment screening regime giving Treasury authority to block or condition Chinese-linked tech investments, bans on Pentagon contracting with certain Chinese biotech and component suppliers, new Regional China Officers and biennial China-presence reports, and repeal of two older Iraq-era war authorizations (1992, 2002) while leaving the 2001 AUMF intact.

Analysis

The House approved the FY National Defense Authorization Act by a 312–112 vote, moving a negotiated $901 billion Pentagon spending package to the Senate after a narrow 215–211 procedural win that saw four Republicans flip their votes; the bill includes $400 million per year for Ukraine for two years and contains provisions that restrain the administration from reducing troop levels in Europe and South Korea or pausing weapons deliveries to Ukraine. The legislation contains domestic policy and personnel changes—a 4% enlisted pay raise, elimination of DEI policies, a $20 billion cut to programs labeled "obsolete," and a new FBI disclosure requirement for candidate investigations—while omitting IVF coverage and a federal preemption of state AI rules and repealing dormant 1992 and 2002 Iraq-era authorizations but leaving the 2001 AUMF in place. Major economic-security measures establish an outbound investment screening regime giving Treasury authority to block or condition certain China-related technology deals and ban Pentagon contracts with Chinese genetic-sequencing/biotech firms and purchases of advanced batteries, photovoltaic components, displays and critical minerals from entities of concern; the bill also creates new Regional China Officers and biennial China-presence reports. These provisions materially raise regulatory and supply-chain risk for China-exposed technology and biotech companies while providing durable demand and procurement advantages to U.S. defense contractors and domestic suppliers of restricted components.

Key Decisions for Investors

• Consider increasing exposure to U.S. defense primes and domestic suppliers of advanced batteries, photovoltaic components, displays and critical minerals that could capture redirected Pentagon procurement under a $901 billion NDAA, while sizing positions to execution risk and contract timing
• Reduce or hedge exposure to China-exposed technology and biotech equities and to funds likely to invest in the types of deals that would trigger the new Treasury outbound-investment screening regime, pending rule details and enforcement thresholds
• Monitor Treasury and DoD rulemaking and procurement lists closely for named restrictions and reporting requirements, and use upcoming RFPs and biennial China-presence reports as catalysts to re-evaluate specific names
• Maintain caution around political and implementation risk—watch Senate passage, legal challenges, and the administration's compliance with troop and weapons-delivery constraints—as these could alter timing and market implications